GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Paragon Care Ltd (FRA:PXS) » Definitions » Median PS Value

Paragon Care (FRA:PXS) Median PS Value : €1.29 (As of Dec. 15, 2024)


View and export this data going back to . Start your Free Trial

What is Paragon Care Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Paragon Care's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was €1.58. Paragon Care's 10-Year median PS Ratio is 0.8165. Therefore, the Median PS Value for today is €1.29.

As of today (2024-12-15), Paragon Care's share price is €0.288. Paragon Care's Median PS Value is €1.29. Therefore, Paragon Care's Price to Median PS Value for today is 0.23.

The historical rank and industry rank for Paragon Care's Median PS Value or its related term are showing as below:

FRA:PXS' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.2   Med: 0.5   Max: 0.62
Current: 0.23

During the past 13 years, the highest Price to Median PS Value of Paragon Care was 0.62. The lowest was 0.20. And the median was 0.50.

FRA:PXS's Price-to-Median-PS-Value is ranked better than
95.31% of 64 companies
in the Medical Distribution industry
Industry Median: 0.93 vs FRA:PXS: 0.23

Paragon Care Median PS Value Historical Data

The historical data trend for Paragon Care's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paragon Care Median PS Value Chart

Paragon Care Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.36 0.34 0.27 0.21 1.31

Paragon Care Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 - 0.21 - 1.31

Competitive Comparison of Paragon Care's Median PS Value

For the Medical Distribution subindustry, Paragon Care's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Paragon Care's Price-to-Median-PS-Value Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Paragon Care's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Paragon Care's Price-to-Median-PS-Value falls into.



Paragon Care Median PS Value Calculation

Paragon Care's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=1.58*0.8165
=1.29

10-Year Median PS Ratio is 0.8165.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Paragon Care's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was €1.58.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Paragon Care  (FRA:PXS) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Paragon Care's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=0.288/1.29
=0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Paragon Care Median PS Value Related Terms

Thank you for viewing the detailed overview of Paragon Care's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Paragon Care Business Description

Traded in Other Exchanges
Address
77-97 Ricketts Road, Mount Waverley, Melbourne, VIC, AUS, 3149
Paragon Care Ltd is a medical device company. The company provides medical equipment, devices, and consumables medical products to the healthcare market. The company provides solutions to various healthcare markets, aged care, and veterinary markets. The group is organized into two operating segments: ParagonCare and CH2 Holdings and the majority of its revenues are generated from the CH2 Holdings segment engaged in the distribution of pharmaceuticals, medical consumables, nutritional, and over-the-counter products to the healthcare market.